Pittsburgh, PANCT05184088Now EnrollingIRB Ready

Cardiac Amyloidosis Clinical Trial in Pittsburgh, PA

Access cutting-edge cardiac amyloidosis treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.

Sponsored by Life Molecular Imaging GmbH

Quick Self-Assessment

See if you qualify for this Pittsburgh location

Preparing your pre-screening questions...

Expert Care in Pittsburgh

Access cardiac amyloidosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cardiac amyloidosis treatment provided free

Apply for This Pittsburgh Location

Check if you qualify for this cardiac amyloidosis clinical trial in Pittsburgh, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Pittsburgh

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Pittsburgh site if eligible
  4. 4Begin participation

About This Cardiac Amyloidosis Study in Pittsburgh

This is an open-label, multi-center pivotal Phase 3 study to visually and quantitatively assess PET images obtained after single application of 300 MBq \[18F\]florbetaben and PET scanning of patients with suspected cardiac amyloidosis.

Sponsor: Life Molecular Imaging GmbH

Who Can Participate

Inclusion Criteria

Males and females age ≥18 years
Able to understand, sign and date written informed consent
Written informed consent must be obtained before any study procedures are performed
Subjects being considered for a possible diagnosis of cardiac amyloidosis by
1\. One of the following conditions:
Established systemic amyloidosis without proven cardiac involvement,
Known plasma cell dyscrasia (MGUS, multiple myeloma),
Pathological free light chain levels in urine or serum,
Presence of heart failure with preserved ejection fraction
2\. AND one of the following parameters, indicative of cardiac manifestation:
Mean (left ventricular (LV) wall + septum) thickness \>12mm as measured by echocardiography or CMR in absence of other known cause of left ventricular hypertrophy (LVH),
NT-proBNP \>335 ng/L (in case a value for NT-proBNP is not available, BNP \> 81ng/L may be used instead)
Planned diagnostic procedure to establish diagnosis and car

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Pittsburgh?

Yes, this clinical trial (NCT05184088) has an active research site in Pittsburgh, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cardiac Amyloidosis Treatment Options in Pittsburgh, PA

If you're searching for cardiac amyloidosis treatment options in Pittsburgh, PA, this clinical trial (NCT05184088) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cardiac amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cardiac amyloidosis clinical trials near you to find additional studies recruiting in your area.

More Amyloidosis Trials in Pittsburgh, PA

See all amyloidosis clinical trials recruiting in Pittsburgh — not just this study.

Browse Amyloidosis Trials in Pittsburgh

Ready to Join in Pittsburgh?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Pittsburgh, PA